Heartflow (NASDAQ:HTFL) CFO Vikram Verghese Sells 4,593 Shares of Stock

Heartflow, Inc. (NASDAQ:HTFL) CFO Vikram Verghese sold 4,593 shares of Heartflow stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $50.24, for a total value of $230,752.32. Following the transaction, the chief financial officer directly owned 180,196 shares in the company, valued at approximately $9,053,047.04. The trade was a 2.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

• On Tuesday, September 15th, Vikram Verghese sold 668 shares of Heartflow stock. The shares were sold at an average price of $50.01, for a total value of $33,406.68.
• On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The stock was sold at an average price of $50.06, for a total transaction of $1,487,482.84.
• On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The shares were sold at an average price of $50.03, for a total transaction of $332,199.20.
• On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The stock was sold at an average price of $49.69, for a total transaction of $1,368,462.60.
• On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The stock was sold at an average price of $50.60, for a total transaction of $297,325.60.

Heartflow Stock Performance

HTFL opened at $48.33 on Wednesday. Heartflow, Inc. has a fifty-two week low of $20.13 and a fifty-two week high of $51.78. The firm’s fifty day moving average is $36.39 and its 200 day moving average is $31.21. The stock has a market cap of $4.20 billion and a price-to-earnings ratio of -26.41.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. The business had revenue of $64.08 million during the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The company’s revenue was up 47.7% on a year-over-year basis. On average, equities research analysts predict that Heartflow, Inc. will post -0.75 earnings per share for the current year.

Analysts Set New Price Targets

HTFL has been the topic of several recent analyst reports. Robert W. Baird set a $45.00 target price on Heartflow in a research note on Friday, August 14th. UBS Group initiated coverage on shares of Heartflow in a report on Wednesday, September 9th. They set a “neutral” rating and a $55.00 price objective for the company. Benchmark reiterated a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. JPMorgan Chase & Co. boosted their target price on shares of Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. Finally, Canaccord Genuity Group raised their target price on shares of Heartflow from $37.00 to $45.00 and gave the company a “buy” rating in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $44.88.

Institutional Investors Weigh In On Heartflow

A number of hedge funds have recently bought and sold shares of the business. Engineers Gate Manager LP purchased a new stake in shares of Heartflow during the 2nd quarter valued at about $590,000. Integrated Wealth Concepts LLC purchased a new position in Heartflow in the second quarter worth about $53,000. Squarepoint Ops LLC grew its position in Heartflow by 72.0% in the second quarter. Squarepoint Ops LLC now owns 87,052 shares of the company’s stock worth $2,554,000 after acquiring an additional 36,441 shares in the last quarter. Arizona State Retirement System bought a new stake in Heartflow during the second quarter worth approximately $312,000. Finally, Allianz Asset Management GmbH purchased a new stake in Heartflow during the second quarter valued at approximately $1,557,000.

Heartflow News Roundup

Here are the key news stories impacting Heartflow this week:

• Positive Sentiment: Heartflow’s latest quarterly results showed strong operating momentum: revenue rose 47.7% year over year to $64.08 million, while its $0.07-per-share loss was narrower than analysts expected. Heartflow stock and earnings information
• Positive Sentiment: Several institutions recently initiated or increased positions, including Squarepoint Ops, which lifted its stake by 72%, providing a potential source of buying support.
• Positive Sentiment: Analyst sentiment remains broadly favorable, with a consensus “Moderate Buy” rating. UBS set a $55 price target, above the recent trading range, while other firms maintained Buy or Overweight ratings.
• Neutral Sentiment: The CFO’s sales were disclosed as part of a planned trading program, reducing the likelihood that the transactions represent a new negative view of Heartflow’s business. After selling 35,?—actually 35,? shares across September 11–15, CFO Vikram Verghese still owned roughly 179,528 shares.
• Negative Sentiment: CFO Vikram Verghese sold a combined 34,975 shares for approximately $1.75 million at prices near $50 per share, reducing his direct ownership by roughly 16.7% over the reported transactions. CFO SEC filing
• Negative Sentiment: CEO John Farquhar also sold 38,900 shares for approximately $1.82 million on September 10–11 and has reported multiple sales since June. The repeated selling by senior executives, particularly after the stock approached its 52-week high, is likely contributing to short-term pressure. HeartFlow CEO share sale

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).